NDC Directory Finished Products
Table of FINISHED Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | RxNorm | Status | |
---|---|---|---|---|---|---|---|---|
0002-8148 | Humatrope | Somatropin | Kit | Intramuscular; Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8149 | Humatrope | Somatropin | Kit | Intramuscular; Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8207 | Lyumjev KwikPen | Insulin Lispro-aabc | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8213 | Humalog Tempo Pen | Insulin Lispro | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8214 | Basaglar Tempo Pen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8215 | Humulin R | Insulin Human | Injection, Solution | Parenteral | Eli Lilly And Company | ACTIVE | ||
0002-8222 | Insulin Lispro KwikPen | Insulin Lispro | Injection, Solution | Intravenous; Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8228 | Lyumjev KwikPen | Insulin Lispro-aabc | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8233 | Insulin Lispro Protamine And Insulin Lispro Injectable Suspension Mix75/25 KwikPen | Insulin Lispro | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8235 | Lyumjev Tempo Pen | Insulin Lispro-aabc | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8315 | Humulin N | Insulin Human | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8400 | Forteo | Teriparatide | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8501 | Humulin R U-500 | Insulin Human | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8715 | Humulin 70/30 | Insulin Human | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8797 | Humalog Mix75/25 KwikPen | Insulin Lispro | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8798 | Humalog Mix50/50 KwikPen | Insulin Lispro | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8799 | Humalog KwikPen | Insulin Lispro | Injection, Solution | Intravenous; Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8803 | Humulin 70/30 KwikPen | Insulin Human | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8805 | Humulin N | Insulin Human | Injection, Suspension | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8824 | Humulin R U-500 KwikPen | Insulin Human | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8900 | Taltz | Ixekizumab | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8905 | Taltz | Ixekizumab | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0002-8980 | Rezvoglar KwikPen | Insulin Glargine-aglr | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | ||
0003-0249 | Halog | Halcinonide | Solution | Topical | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0293 | Kenalog-40 | Triamcinolone Acetonide | Injection, Suspension | Intra-articular; Intramuscular | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0315 | Kenalog-80 | Triamcinolone Acetonide | Injection, Suspension | Intra-articular; Intramuscular | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0371 | Nulojix | Belatacept | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0494 | Kenalog-10 | Triamcinolone Acetonide | Injection, Suspension | Intra-articular; Intralesional | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0524 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0527 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0528 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0830 | Hydrea | Hydroxyurea | Capsule | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0852 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0855 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0857 | Sprycel | Dasatinib | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0893 | Eliquis | Apixaban | Tablet, Film Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0894 | Eliquis | Apixaban | Tablet, Film Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-0895 | Sotyktu | Deucravacitinib | Tablet, Film Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-1611 | Baraclude | Entecavir | Tablet, Film Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-1612 | Baraclude | Entecavir | Tablet, Film Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-1614 | Baraclude | Entecavir | Solution | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2187 | Orencia | Abatacept | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2188 | Orencia | Abatacept | Injection, Solution | Subcutaneous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2291 | Empliciti | Elotuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2327 | Yervoy | Ipilimumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2328 | Yervoy | Ipilimumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2560 | Azactam | Aztreonam | Injection, Powder, For Solution | Intramuscular; Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2570 | Azactam | Aztreonam | Injection, Powder, For Solution | Intramuscular; Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2814 | Orencia | Abatacept | Injection, Solution | Subcutaneous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-2818 | Orencia | Abatacept | Injection, Solution | Subcutaneous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3622 | Reyataz | Atazanavir | Capsule, Gelatin Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3631 | Reyataz | Atazanavir | Capsule, Gelatin Coated | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3638 | Reyataz | Atazanavir | Powder | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3641 | Evotaz | Atazanavir And Cobicistat | Tablet | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3734 | Opdivo | Nivolumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3756 | Opdivo | Nivolumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3764 | Eliquis 30-Day Starter Pack | Apixaban | Kit | E.r. Squibb & Sons, L.l.c. | ACTIVE | |||
0003-3772 | Opdivo | Nivolumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-3774 | Opdivo | Nivolumab | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-4040 | Augtyro | Repotrectinib | Capsule | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-4522 | Empliciti | Elotuzumab | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-6335 | Droxia | Hydroxyurea | Capsule | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-6336 | Droxia | Hydroxyurea | Capsule | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-6337 | Droxia | Hydroxyurea | Capsule | Oral | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0003-7125 | Opdualag | Nivolumab And Relatlimab-rmbw | Injection | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE | ||
0004-0038 | Valcyte | Valganciclovir | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
0004-0039 | Valcyte | Valganciclovir Hydrochloride | Powder, For Solution | Oral | Genentech, Inc. | ACTIVE | ||
0004-0244 | Invirase | Saquinavir Mesylate | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
0004-0259 | Cellcept | Mycophenolate Mofetil | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
0004-0260 | Cellcept | Mycophenolate Mofetil | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
0004-0261 | Cellcept | Mycophenolate Mofetil | Powder, For Suspension | Oral | Genentech, Inc. | ACTIVE | ||
0004-0298 | Cellcept | Mycophenolate Mofetil Hydrochloride | Injection, Powder, Lyophilized, For Solution | Intravenous | Genentech, Inc. | ACTIVE | ||
0004-0350 | Pegasys | Peginterferon Alfa-2a | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
0004-0357 | Pegasys | Peginterferon Alfa-2a | Injection, Solution | Subcutaneous | Genentech, Inc. | ACTIVE | ||
0004-0381 | Fuzeon | Enfuvirtide | Kit | Genentech, Inc. | ACTIVE | |||
0004-0800 | Tamiflu | Oseltamivir Phosphate | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
0004-0801 | Tamiflu | Oseltamivir Phosphate | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
0004-0802 | Tamiflu | Oseltamivir Phosphate | Capsule | Oral | Genentech, Inc. | ACTIVE | ||
0004-0822 | Tamiflu | Oseltamivir Phosphate | Powder, For Suspension | Oral | Genentech, Inc. | ACTIVE | ||
0004-1100 | Xeloda | Capecitabine | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
0004-1101 | Xeloda | Capecitabine | Tablet, Film Coated | Oral | Genentech, Inc. | ACTIVE | ||
0005-0100 | Trumenba | Meningococcal Group B Vaccine | Injection, Suspension | Intramuscular | Wyeth Pharmaceutical Division Of Wyeth Holdings Llc | ACTIVE | ||
0005-1971 | Prevnar 13 | Pneumococcal 13-valent Conjugate Vaccine | Injection, Suspension | Intramuscular | Wyeth Pharmaceutical Division Of Wyeth Holdings Llc | ACTIVE | ||
0005-2000 | Prevnar 20 | Pneumococcal 20-valent Conjugate Vaccine | Injection, Suspension | Intramuscular | Wyeth Pharmaceutical Division Of Wyeth Holdings Llc | ACTIVE | ||
0006-0005 | Belsomra | Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0032 | Stromectol | Ivermectin | Tablet | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0033 | Belsomra | Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0078 | Janumet XR | Sitagliptin And Metformin Hydrochloride | Tablet, Film Coated, Extended Release | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0080 | Janumet XR | Sitagliptin And Metformin Hydrochloride | Tablet, Film Coated, Extended Release | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0081 | Janumet XR | Sitagliptin And Metformin Hydrochloride | Tablet, Film Coated, Extended Release | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0112 | Januvia | Sitagliptin | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0221 | Januvia | Sitagliptin | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0227 | Isentress | Raltegravir | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0277 | Januvia | Sitagliptin | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0325 | Belsomra | Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0335 | Belsomra | Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0461 | Emend | Aprepitant | Capsule | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0462 | Emend | Aprepitant | Capsule | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0464 | Emend | Aprepitant | Capsule | Oral | Merck Sharp & Dohme Llc | ACTIVE | ||
0006-0473 | Isentress | Raltegravir | Tablet, Chewable | Oral | Merck Sharp & Dohme Llc | ACTIVE |
TOTAL FINISHED PRODUCTS: 109,681
TOTAL FINISHED PRODUCTS BY TYPE
HUMAN OTC DRUG PRODUCTS: 53,980
HUMAN PRESCRIPTION DRUG PRODUCTS: 53,048
NON-STANDARDIZED ALLERGENIC PRODUCTS: 2,044
PLASMA DERIVATIVE PRODUCTS: 320
VACCINE PRODUCTS: 141
STANDARDIZED ALLERGENIC PRODUCTS: 126
CELLULAR THERAPY PRODUCTS: 22